In the quest to combat nicotine dependency, vaping cessation treatment has emerged as a critical focus for healthcare professionals and young users alike.A recent study reveals that teens and young adults who utilize varenicline, an FDA-approved smoking cessation medication, are more than three times as likely to successfully quit vaping compared to those relying solely on counseling.
The smoking cessation pill, varenicline, is gaining attention as an effective solution for those struggling with nicotine addiction, particularly among teens and young adults battling the vaping epidemic.Recent clinical trials conducted by Mass General Brigham have revealed that participants using this FDA-approved smoking aid are more than three times as likely to successfully quit vaping compared to those relying solely on behavioral therapy.